vs
NACCO INDUSTRIES INC（NC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
NACCO INDUSTRIES INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.9倍（$66.8M vs $35.5M），NACCO INDUSTRIES INC净利率更高（-5.8% vs -304.2%，领先298.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -5.2%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 11.9%）
纳科工业是一家总部位于美国俄亥俄州克利夫兰的上市控股公司，核心业务聚焦采矿与自然资源领域，旗下划分煤炭开采、北美采矿、矿产管理三大业务板块。其中煤炭开采板块采用服务型商业模式，依据长期合约为发电企业及活性炭生产商运营露天煤矿。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NC vs RXRX — 直观对比
营收规模更大
NC
是对方的1.9倍
$35.5M
营收增速更快
RXRX
高出686.9%
-5.2%
净利率更高
NC
高出298.5%
-304.2%
两年增速更快
RXRX
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.8M | $35.5M |
| 净利润 | $-3.8M | $-108.1M |
| 毛利率 | 18.0% | 59.8% |
| 营业利润率 | 11.3% | -304.8% |
| 净利率 | -5.8% | -304.2% |
| 营收同比 | -5.2% | 681.7% |
| 净利润同比 | -150.8% | 39.6% |
| 每股收益（稀释后） | $-0.53 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCRXRX
| Q4 25 | $66.8M | $35.5M | ||
| Q3 25 | $76.6M | $5.2M | ||
| Q2 25 | $68.2M | $19.2M | ||
| Q1 25 | $65.6M | $14.7M | ||
| Q4 24 | $70.4M | $4.5M | ||
| Q3 24 | $61.7M | $26.1M | ||
| Q2 24 | $52.3M | $14.4M | ||
| Q1 24 | $53.3M | $13.8M |
净利润NCRXRX
| Q4 25 | $-3.8M | $-108.1M | ||
| Q3 25 | $13.3M | $-162.3M | ||
| Q2 25 | $3.3M | $-171.9M | ||
| Q1 25 | $4.9M | $-202.5M | ||
| Q4 24 | $7.6M | $-178.9M | ||
| Q3 24 | $15.6M | $-95.8M | ||
| Q2 24 | $6.0M | $-97.5M | ||
| Q1 24 | $4.6M | $-91.4M |
毛利率NCRXRX
| Q4 25 | 18.0% | 59.8% | ||
| Q3 25 | 13.0% | -183.8% | ||
| Q2 25 | 10.0% | -4.9% | ||
| Q1 25 | 14.7% | -48.0% | ||
| Q4 24 | 12.0% | -181.4% | ||
| Q3 24 | 11.7% | 53.7% | ||
| Q2 24 | 13.4% | 36.2% | ||
| Q1 24 | 13.2% | 19.1% |
营业利润率NCRXRX
| Q4 25 | 11.3% | -304.8% | ||
| Q3 25 | 8.8% | -3327.6% | ||
| Q2 25 | -0.1% | -916.8% | ||
| Q1 25 | 11.7% | -1297.9% | ||
| Q4 24 | 5.5% | -4042.4% | ||
| Q3 24 | 31.9% | -377.1% | ||
| Q2 24 | 14.1% | -697.4% | ||
| Q1 24 | 8.9% | -698.4% |
净利率NCRXRX
| Q4 25 | -5.8% | -304.2% | ||
| Q3 25 | 17.3% | -3135.3% | ||
| Q2 25 | 4.8% | -894.2% | ||
| Q1 25 | 7.5% | -1373.3% | ||
| Q4 24 | 10.7% | -3935.5% | ||
| Q3 24 | 25.4% | -367.5% | ||
| Q2 24 | 11.4% | -676.6% | ||
| Q1 24 | 8.6% | -662.4% |
每股收益（稀释后）NCRXRX
| Q4 25 | $-0.53 | $-0.17 | ||
| Q3 25 | $1.78 | $-0.36 | ||
| Q2 25 | $0.44 | $-0.41 | ||
| Q1 25 | $0.66 | $-0.50 | ||
| Q4 24 | $0.99 | $-0.56 | ||
| Q3 24 | $2.14 | $-0.34 | ||
| Q2 24 | $0.81 | $-0.40 | ||
| Q1 24 | $0.61 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.7M | $743.3M |
| 总债务越低越好 | $100.8M | $9.6M |
| 股东权益账面价值 | $429.2M | $1.1B |
| 总资产 | $661.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.23× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资NCRXRX
| Q4 25 | $49.7M | $743.3M | ||
| Q3 25 | $52.7M | $659.8M | ||
| Q2 25 | $49.4M | $525.1M | ||
| Q1 25 | $61.9M | $500.5M | ||
| Q4 24 | $72.8M | $594.4M | ||
| Q3 24 | $63.1M | $427.6M | ||
| Q2 24 | $62.4M | $474.3M | ||
| Q1 24 | $61.8M | $296.3M |
总债务NCRXRX
| Q4 25 | $100.8M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $99.4M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | $29.0M | $22.9M | ||
| Q1 24 | $28.4M | — |
股东权益NCRXRX
| Q4 25 | $429.2M | $1.1B | ||
| Q3 25 | $426.4M | $1.0B | ||
| Q2 25 | $413.1M | $919.1M | ||
| Q1 25 | $409.1M | $933.9M | ||
| Q4 24 | $404.9M | $1.0B | ||
| Q3 24 | $397.3M | $524.6M | ||
| Q2 24 | $384.1M | $584.4M | ||
| Q1 24 | $381.6M | $401.2M |
总资产NCRXRX
| Q4 25 | $661.2M | $1.5B | ||
| Q3 25 | $637.6M | $1.4B | ||
| Q2 25 | $631.3M | $1.3B | ||
| Q1 25 | $634.2M | $1.3B | ||
| Q4 24 | $631.7M | $1.4B | ||
| Q3 24 | $597.4M | $726.5M | ||
| Q2 24 | $560.1M | $775.9M | ||
| Q1 24 | $538.0M | $557.8M |
负债/权益比NCRXRX
| Q4 25 | 0.23× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.25× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | 0.08× | 0.04× | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流NCRXRX
| Q4 25 | $11.4M | $-46.1M | ||
| Q3 25 | $42.3M | $-117.4M | ||
| Q2 25 | $-7.8M | $-76.4M | ||
| Q1 25 | $5.0M | $-132.0M | ||
| Q4 24 | $25.2M | $-115.4M | ||
| Q3 24 | $2.8M | $-59.2M | ||
| Q2 24 | $4.1M | $-82.2M | ||
| Q1 24 | $-9.8M | $-102.3M |
自由现金流NCRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率NCRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度NCRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率NCRXRX
| Q4 25 | — | — | ||
| Q3 25 | 3.19× | — | ||
| Q2 25 | -2.39× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 3.33× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | -2.14× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
RXRX
暂无分部数据
